Amylin Pharmaceuticals 'modified exendins and exendin agonists patent: USPTO issues Final
THE MEDICAL NEWS
The firm's diabetes drug is called CVX-096 and follows preclinical work on Glucagon-like peptide 1 (GLP-1) and exendin peptides.
Log in or sign up to add your own related words.
Log in or sign up to get involved in the conversation. It's quick and easy.
Wordnik is a 501(c)(3) non-profit organization, EIN #47-2198092.